Discussion about this post

User's avatar
Robots and Chips's avatar

The timing of AB's EMOP launch in mid-June seems strategic given the EM opportunities you highlighted, though the acive management fee will be key to watch. AllianceBernstein has solid research capabilities in developed markets, but their success in EM will depend on local market relationships and nimble positioning across these diverse geographies. The fund structure targeting institutional investors makes sense given the complexity and volatility, but retail access could be limited. Their track record in fixed income is strong, so it'll be interesting to see how they navigate equity volatility in emerging markets.

Expand full comment

No posts